The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
Жители Санкт-Петербурга устроили «крысогон»17:52
，更多细节参见夫子
Мощный удар Израиля по Ирану попал на видео09:41
$10 per month for Verizon customers with myPlan